Intervention Review

You have free access to this content

Antenatal immunoglobulin for fetal red blood cell alloimmunization

  1. Kae Sheen Wong1,*,
  2. Kirsten Connan2,
  3. Shelley Rowlands2,
  4. Louise H Kornman3,
  5. Helen F Savoia4

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 31 MAY 2013

Assessed as up-to-date: 13 DEC 2012

DOI: 10.1002/14651858.CD008267.pub2


How to Cite

Wong KS, Connan K, Rowlands S, Kornman LH, Savoia HF. Antenatal immunoglobulin for fetal red blood cell alloimmunization. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD008267. DOI: 10.1002/14651858.CD008267.pub2.

Author Information

  1. 1

    The Royal Women's Hospital, Department of Obstetrics and Gynaecology, Parkville, Victoria, Australia

  2. 2

    The Royal Women's Hospital, Department of Perinatal Medicine, Parkville, Victoria, Australia

  3. 3

    The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria, Australia

  4. 4

    Royal Children's Hospital, Laboratory Services, Parkville, Victoria, Australia

*Kae Sheen Wong, Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Corner of Grattan Street and Flemington Road, Parkville, Victoria, 3052, Australia. kaewong@optusnet.com.au.

Publication History

  1. Publication Status: New
  2. Published Online: 31 MAY 2013

SEARCH

References

Additional references

Ballow 1991
Berlin 1985
Cantu 1995
Chitkara 1990
  • Chitkara U, Bussel J, Alvarez M, Lynch L, Meisel RL, Berkowitz RL. High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis?. Obstetrics & Gynecology 1990;76(4):703-8.
Clark 1999
Connan 2009
  • Connan K, Kornman L, Savoia H, Palma-Dias R, Rowlands S. IVIG - Is it the answer? Maternal administration of immunoglobulin for severe fetal red blood cell alloimmunisation during pregnancy: a case series. Australian and New Zealand Journal of Obstetrics and Gynaecology 2009;49:612-8.
Deka 1996
  • Deka D, Buckshee K, Kinra G. Intravenous immunoglobulin as primary therapy or adjuvant therapy to intrauterine fetal blood transfusion: a new approach in the management of severe Rh-immunization. Journal of Obstetrics and Gynaecology Research 1996;22(6):561-7.
Dooren 1994
Duhem 1994
  • Duhem C, Dicato MA, Ries F. Side-effects of intravenous immune globulins. Clinical and Experimental Immunology 1994;97(Suppl 1):79-83.
Egger 1997
Fox 2008
  • Fox C, Martin W, Somerset DA, Thompson PJ, Kilby MD. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunisation prior to fetal intravascular transfusion. Fetal Diagnosis and Therapy 2008;23:159-63.
Geifman-Holtzman 1997
Gottvall 1995
Harbord 2006
Higgins 2011
  • Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Kriplani 2007
Margulies 1991
Mari 2000
  • Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anaemia due to maternal red-cell alloimmunization. New England Journal of Medicine 2000;342(1):9-14.
Odendaal 1986
  • Odendaal HJ, King JB, Oosthuizen OJ. Severe rhesus iso-immunisation successfully treated with apheresis and azathioprine. South African Medical Journal 1986;69(2):122-4.
Oepkes 2006
  • Oepkes D, Seaward PG, Vandenbussche FP, Windrim R, Kingdom J, Beyene J, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. New England Journal of Medicine 2006;355(2):156-64.
Porter 1997
  • Porter TF, Silver RM, Jackson GM, Branch DW, Scott JR. Intravenous immune globulin in the management of severe Rh D hemolytic disease. Obstetrical & Gynecological Survey 1997;52(3):193-7.
Queenan 1969
Rayment 2005
RevMan 2011 [Computer program]
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Ruma 2007
  • Ruma MS, Moise KJ Jr, Kim E, Murtha AP, Prutsman WJ, Hassan SS, et al. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization. American Journal of Obstetrics and Gynecology 2007;196(2):138.e1-138.e6.
Ulm 1999
van Kamp 2005
  • Van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP, et al. Complications of intrauterine intravascular transfusion to fetal anaemia due to maternal red-cell alloimmunization. American Journal of Obstetrics and Gynecology 2005;192:171-7.
van Wamelen 2007
  • van Wamelen DJ, Klumper FJ, de Haas M, Meerman RH, van Kamp IL, Oepkes D, et al. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy. Obstetrics & Gynecology 2007;109(5):1093-8.
Voto 1997
  • Voto LS, Mathet ER, Zapaterio JL, Orti J, Lede RL, Margulies M. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal haemolytic disease. Journal of Perinatal Medicine 1997;25(1):85-8.
Watson 2006
  • Watson WJ, Wax JR, Miller RC, Brost BC. Prevalence of new maternal alloantibodies after intrauterine transfusion for severe rhesus disease. American Journal of Perinatology 2006;23(3):189-92.